Commentary Open Access
Volume 4 | Issue 1 | DOI: https://doi.org/10.46439/immunol.4.033
The role of EMMPRIN in Marfan syndrome-related thoracic aortic aneurysms: A commentary
Shannon Parness1, Panagiotis Tasoudis2,*
- 1University of North Carolina School of Medicine, 321 S Columbia St, Chapel Hill, NC 27599, USA
- 2Department of Surgery, Division of Cardiothoracic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
Corresponding Author
Panagiotis Tasoudis, Panagiotis.Tasoudis2@unchealth.unc.edu
Received Date: September 09, 2024
Accepted Date: April 05, 2025
Parness S, Tasoudis P. The role of EMMPRIN in Marfan syndrome-related thoracic aortic aneurysms: A commentary. J Cell Mol Immunol. 2025;4(1):9-10.
Copyright: © 2025 Parness S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Thoracic outlet syndrome: Its complexity is not disputed
Thoracic Outlet Syndrome (TOS) has a complex history that has led to misunderstanding and confusion from physicians. We review the history of TOS to better understand where this confusion comes from.
Surgical management of spontaneous hepatic rupture associated with HELLP syndrome. Case presentation and literature review
HELLP syndrome (hemolysis, elevated liver blood tests and low platelets) is a serious complication in pregnancy characterized by hemolysis, elevated liver enzymes and low platelet count occurring in 0.2 to 0.6% of all pregnancies and in 10–20% of cases with severe preeclampsia
Theory on the involvement of retroviruses and EBV in autoimmunity
There is a striking likeness between an old model for the action of mobile genetic elements in Maize and recent observations on endogenous retroviruses in human Multiple Sclerosis. Nexø discussed this and other developments in his recent theory on autoimmunity. Specifically, in analogy to the onc genes Nexø suggest that insertion of a retrovirus activates a so-called aut gene. This aut gene may well be an EBV genome.
The significance of triple-capsid-mutant AAV8 for treatment of Sanfilippo Syndrome Type B
Sanfilippo Syndrome Type-B remains an untreatable childhood neurodegenerative disease with great burden for both patient and caregiver. Very few clinical trials have been undertaken to treat the disease, and none of these have yet yielded clinically obtainable products for patients. Caused by a simple enzyme function deficiency, Sanfilippo Syndrome Type-B has been considered a great prospect for gene-therapy interventions.
Can regulatory-driven process innovation open the door for cellular therapies in emerging markets?
Due to their impressive clinical success, CAR-T therapies are becoming a more mainstream treatment for patients with hematologic malignancies. In order to make this promising form of therapy accessible to patients in need worldwide, a robust scale-up of such a complex supply chain, that is also affordable worldwide, is essential. Already a challenging endeavor in most privileged countries, but a chimerical undertaking in the more logistically challenged regions and emerging markets across the globe.